Abeona Therapeutics Inc. (LON:0H7R)
London · Delayed Price · Currency is GBP · Price in USD 4.969
-0.060 (-1.19%)
Feb 12, 2026, 4:51 PM GMT
Abeona Therapeutics Market Cap
Abeona Therapeutics has a market cap or net worth of 198.51 million as of February 12, 2026. Its market cap has increased by 4.97% in one year.
Market Cap
198.51M
Enterprise Value
64.16M
Revenue
297.58K
Ranking
n/a
PE Ratio
3.24
Stock Price
4.97
Market Cap Chart
Since January 26, 1996, Abeona Therapeutics's market cap has increased from 6.64M to 198.51M, an increase of 2,891.81%. That is a compound annual growth rate of 11.97%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 11, 2026 | 200.97M | -5.29% |
| Dec 31, 2025 | 212.19M | 9.71% |
| Dec 31, 2024 | 193.41M | 98.49% |
| Dec 29, 2023 | 97.44M | 121.93% |
| Dec 30, 2022 | 43.91M | 20.32% |
| Dec 31, 2021 | 36.49M | -67.79% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 229.82B |
| GSK plc | 86.28B |
| Haleon | 36.19B |
| Smith & Nephew | 10.90B |
| NIOX Group | 272.49M |
| Avacta Group | 260.26M |
| Integrated Diagnostics Holdings | 259.90M |
| Tristel | 203.19M |